ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 39 filers reported holding ATYR PHARMA INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $46,000 | -54.5% | 125,916 | -31.3% | 0.00% | – |
| Q1 2019 | $101,000 | +8.6% | 183,225 | -1.9% | 0.00% | – |
| Q4 2018 | $93,000 | -45.0% | 186,738 | -9.9% | 0.00% | – |
| Q3 2018 | $169,000 | -40.1% | 207,281 | -33.3% | 0.00% | – |
| Q2 2018 | $282,000 | -72.3% | 310,903 | -19.1% | 0.00% | – |
| Q1 2018 | $1,019,000 | -20.5% | 384,517 | +5.0% | 0.00% | – |
| Q4 2017 | $1,281,000 | -51.3% | 366,047 | -29.8% | 0.00% | – |
| Q3 2017 | $2,633,000 | +42.8% | 521,445 | -3.8% | 0.00% | – |
| Q2 2017 | $1,844,000 | -8.8% | 542,198 | -6.1% | 0.00% | – |
| Q1 2017 | $2,021,000 | +4711.9% | 577,171 | +2832.9% | 0.00% | – |
| Q4 2016 | $42,000 | -41.7% | 19,679 | -13.2% | 0.00% | – |
| Q3 2016 | $72,000 | +14.3% | 22,662 | -0.3% | 0.00% | – |
| Q2 2016 | $63,000 | – | 22,732 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $3,930,000 | 4.66% |
| EcoR1 Capital, LLC | 976,986 | $2,101,000 | 0.67% |
| TANG CAPITAL MANAGEMENT LLC | 279,425 | $601,000 | 0.32% |
| Rock Springs Capital Management LP | 475,000 | $1,021,000 | 0.07% |
| Quotient Investors, LLC | 22,200 | $48,000 | 0.03% |
| Alyeska Investment Group, L.P. | 1,072,108 | $2,305,000 | 0.02% |
| TIVERTON ASSET MANAGEMENT LLC | 95,318 | $205,000 | 0.01% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 79,677 | $171,000 | 0.01% |
| Acrospire Investment Management LLC | 12,683 | $27,000 | 0.01% |
| Glen Harbor Capital Management LLC | 179,724 | $386,000 | 0.01% |